CPS1 and hepatocellular carcinoma: Similarly, Wu et al discovered that HCC patients with poor prognosis exhibited carbamoyl phosphate synthetase 1 (CPS1) deficiency, which activates AMPK to elevate FAO, consequently rendering chemotherapy resistance to HCC.38